PBM

Propel Bio Management Portfolio holdings

AUM $159M
1-Year Est. Return 60.94%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+60.94%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$99.9M
AUM Growth
+$17.5M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
21
New
Increased
Reduced
Closed

Top Buys

1
+$5.86M
2
+$3.59M
3
+$3.12M
4
DCTH icon
Delcath Systems
DCTH
+$2.37M
5
CMPS
Compass Pathways
CMPS
+$2.29M

Top Sells

1
+$6.5M
2
+$3.82M
3
+$695K
4
EIGR
Eiger BioPharmaceuticals, Inc.
EIGR
+$423K
5
TCRX icon
TScan Therapeutics
TCRX
+$274K

Sector Composition

1 Healthcare 76.77%
2 Energy 23.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$23.2M 23.23%
1,272,360
2
$11.9M 11.94%
3,786,425
-2,366,666
3
$10.9M 10.88%
228,884
4
$10.2M 10.26%
5,124,890
+3,333,333
5
$6.83M 6.83%
11,285,420
6
$6.51M 6.51%
552,927
-370,000
7
$5.14M 5.15%
974,022
8
$4.71M 4.72%
438,509
+212,457
9
$4.01M 4.01%
+155,000
10
$3.52M 3.52%
1,932,304
-154,835
11
$2.92M 2.93%
+510,000
12
$2.79M 2.79%
+49,000
13
$2.45M 2.45%
+1,028,806
14
$2.21M 2.21%
231,874
15
$1.94M 1.94%
+90,000
16
$618K 0.62%
149,279
17
– –
-70,000
18
– –
-146,381